The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

被引：121
|
作者：
Zauli, Giorgio
Secchiero, Paola
机构：
[1] Univ Trieste, Inst Normal Human Morphol, I-34138 Trieste, Italy
[2] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy
来源：
CYTOKINE & GROWTH FACTOR REVIEWS | 2006年 / 17卷 / 04期
关键词：
TRAIL; hematopoiesis; endothelial cells; TRAIL receptors; OPG;
D O I：
10.1016/j.cytogfr.2006.04.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：245 / 257
页数：13
相关论文
共 50 条
  • [11] Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: Evidence for a role of TRAIL in eosinophil survival
    Robertson, NM
    Zangrilli, JG
    Steplewski, A
    Hastie, A
    Lindemeyer, RG
    Planeta, MA
    Smith, MK
    Innocent, N
    Musani, A
    Pascual, R
    Peters, S
    Litwack, G
    JOURNAL OF IMMUNOLOGY, 2002, 169 (10): : 5986 - 5996
  • [12] Expression of TRAIL and TRAIL receptors in normal and malignant tissues
    Raymond A DANIELS
    Helen TURLEY
    Fiona C KIMBERLEY
    Juthathip MONGKOLSAPAYA
    Paul CH’EN
    Francesco PEZZELLA
    Gavin R SCREATON
    CellResearch, 2005, (06) : 430 - 438
  • [13] Expression of TRAIL and TRAIL receptors in normal and malignant tissues
    Raymond A DANIELS
    Helen TURLEY
    Fiona C KIMBERLEY
    Xue Song LIU
    Juthathip MONGKOLSAPAYA
    Paul CH'EN
    Xiao Ning XU
    Boquan JIN
    Francesco PEZZELLA
    Gavin R SCREATON
    Cell Research, 2005, 15 : 430 - 438
  • [14] Macrophages from cancer patients: Analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis
    Herbeuval, JP
    Lambert, C
    Sabido, O
    Cottier, M
    Fournel, P
    Dy, M
    Genin, C
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08): : 611 - 621
  • [15] The role of TRAIL death receptors in the treatment of hematological malignancies
    Henson, Elizabeth S.
    Johnston, James B.
    Gibson, Spencer B.
    LEUKEMIA & LYMPHOMA, 2008, 49 (01) : 27 - 35
  • [16] Characterization of monoclonal antibodies directed against trail or trail receptors
    Vermot-Desroches, C
    Sergent, E
    Bonnin, B
    Wijdenes, J
    CELLULAR IMMUNOLOGY, 2005, 236 (1-2) : 86 - 91
  • [17] Targeting TRAIL Death Receptors: TRAIL from the Lab to the Clinic
    De Jong, S.
    De Vries, E. G. E.
    KLINISCHE PADIATRIE, 2011, 223 (01): : 47 - 47
  • [18] BIOLOGY AND BIOLOGISTS OF THE BUCKEYE TRAIL
    DANIEL, PM
    OHIO JOURNAL OF SCIENCE, 1987, 87 (01) : 2 - 9
  • [19] Expression of TRAIL and TRAIL receptors in colon carcinoma:: TRAIL-R1 is an independent prognostic parameter
    Sträter, J
    Hinz, U
    Walczak, H
    Mechtersheimer, G
    Koretz, K
    Herfarth, C
    Möller, P
    Lehnert, T
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3734 - 3740
  • [20] Targeting TRAIL death receptors
    Oldenhuis, C. N. A. M.
    Stegehuis, J. H.
    Walenkamp, A. M. E.
    de Jong, S.
    de Vries, E. G. E.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (04) : 433 - 439
12345